The inhibition of T cells by tumour cells occurs through two main inhibitory pathways: the cytotoxic T-lymphocyte antigen 4 (CTLA-4) protein receptor and programmed cell death protein 1 (PD-1) [13,14]. This evidence concerns the gene PDCD1 and neoplasm.